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Thyroid cancerThyroid carcinomas account for a minority of all malignant tumours but, after those of the
gonads, they represent the most common forms of endocrine cancers. They include several
types, among which the papillary thyroid cancer (PTC) and the anaplastic thyroid cancer (ATC) are
the best known. The two hystotypes display significant biological and clinical differences: PTC
is a well differentiated form of tumour with a high incidence and a good prognosis, while the
ATC is less frequent but represents one of the most aggressive endocrine tumours with
morphological features of an undifferentiated type. To date, as far as we know, no conclusive
studies, useful to design arrays of molecular markers, have been published illustrating the
phenotypic and proteomic differences between these two tumours. The aim of this work was
to perform a comparative analysis of two thyroid cancer cell lines, derived respectively from
papillary (BCPAP) and anaplastic (8505C) thyroid carcinomas. The comparative analysis
included cell behaviour assays and proteomic analysis by 2D-PAGE and mass spectrometry.
The results have highlighted a new proteomic signature for the anaplastic carcinoma-derived
cells, consistent with their high proliferation rate, motility propensity and metabolic shift, in
relation to the well-differentiated PTC cells.
This article is part of a Special Issue entitled: From Genome to Proteome: Open Innovations.
© 2013 Published by Elsevier B.V.Papillary
Anaplastic
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Proteomics1. Introduction
Thehuman thyroid gland is composed of a basic structural unit,
the follicle, consisting of a monolayer of well polarized cells, the
thyrocytes, responsible for the T3/T4 hormone secretion, and of
other peripheral cells, the parafollicular C cells, responsible for the
secretion of calcitonin. The presence within the follicle of stemled: From Genome to Prot
ntal Oncobiology (C.OB.S.),
806418; fax: +39 091680641
ci-Minafra).
hed by Elsevier B.V.
ifferential proteomic and
6/j.jprot.2013.01.023cells, or remnants of embryonic cells, has been hypothesized as
the target cells for tumour initiation.A thin extracellularmatrix,
which includes occasional fibroblasts and inflammatory cells, is
peripheral to the follicle structure.
Thyroid carcinomas account for 1–2% of all malignant
tumours and, after those of the gonads, they represent the
most common tumours of the endocrine system. The thyroideome: Open Innovations.
“LaMaddalena”Hospital III Level Oncological Dept., Via San Lorenzo
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profiles, as well as biological and clinical behaviours.
Among these, papillary (PTC) and anaplastic (ATC) histotypes
are probably the most investigated. The two hystotypes display
significant phenotypic differences, as well as dissimilar clinical
occurrences and outcomes. Indeed, PTC is a well differentiated
form of tumour with a high incidence, representing approxi-
mately 80% of all thyroid tumours and is characterized by a good
prognosis [1]. On the contrary, ATC accounts for less than 5%,
but it is one of the most aggressive endocrine tumours with
morphological features of an undifferentiated type.
However, to date no studies have definitely demonstrated
whether malignant forms of thyroid tumours arise from the
adult epithelial cells through multistep cancerogenesis [2] or
from remnants of foetal thyroid cells [3] or, as more recently
hypothesized, from resident stem cells [4–6].
Many genetic alterations have been described as involved in
the progression, mostly leading to the anomalous activation of
the MAP kinase pathway. Several studies have suggested that
BRAF(V600E) mutation (90% of all BRAF mutations) plays an
important role in the early steps of the thyroid carcinogenesis
leading to the progression towards the anaplastic forms [7–10],
but some controversies about its significance still remain.
Therefore, the biological mechanisms of thyroid cancer-
ogenesis are still unclear. This is also because the panels of
putative biomarkers for thyroid cancer histotypes are not yet
adequate enough to fulfil the requirements for molecular
diagnosis, prognosis and target therapy. We suggest that the
increase in knowledge of protein expression in thyroid
tumours, as for the breast cancer [11–13], could greatly help
to understand molecular mechanisms involved in the thyroid
carcinogenesis. With this aim, we performed a comparative
analysis of two thyroid cancer cell lines, derived respectively
from papillary (BCPAP) and anaplastic (8505C) thyroid carcino-
mas. The comparative analysis included cell behaviour assays,
proteomic analysis by 2D-PAGE and mass spectrometry.
First of all, in this study we show that both PTC and ATC cell
lines closely maintain in vitro phenotypical characteristics,
probably resembling their in vivo counterparts. Indeed, the
8505C cells are characterized by cell traits and a behaviour
typical of the aggressive phenotype associatedwith an advanced
stage of the disease. On the contrary, the BCPAP cells derived
from a more differentiated tumour, maintain in vitro a rather
stable phenotype and the ability to reorganize “follicle-like”
structures. Our findings confirm that these cell lines represent
an important model for the in vitro study of differentiated and
undifferentiated thyroid tumours and may offer new insights
into the thyroid carcinogenesis. The proteomic study revealed a
panel of differentially expressed proteins, instrumental for
cancer growth and invasion, which may be used for future
applications as biomarkers of thyroid malignancy.2. Materials and methods
2.1. Cell culture
The human papillary thyroid carcinoma cell line, BCPAP
established in 1992 [14] and human anaplastic thyroid
carcinoma cell line, 8505C established in 1994 [15] werePlease cite this article as: Musso R, et al, Differential proteomic and
lines, J Prot (2013), http://dx.doi.org/10.1016/j.jprot.2013.01.023provided by the Endocrinolgy Labolatory of Prof. C. Giordano.
Cells were seeded at a density of 104 cells/cm2 and grown in
RPMI 1640 (GIBCO), supplemented with 10% foetal bovine
serum (GIBCO), 1% L-glutamine, 1% penicillin and 1% strepto-
mycin in a humidified incubator with 5% CO2 in air at 37 °C.
2.1.1. Cell proliferation
The assay [16] was performed by the use of a colorimetric
tetrazolium compound (CellTiter 96, Promega). Briefly, 20 μl of
CellTiter 96 was added to 100 μl of medium into each well
containing the cells. After 1 h of incubation in a humidified 5%
CO2 atmosphere, the absorbance at 492 nm was read using a
96-well plate reader (Amersham).
2.1.2. Scratch assay
The confluent mono-layers of BCPAP and 8505C cells were
scraped with a p200 pipet tip. Following the “scratch”, the
cells debris were removed by several washes with phosphate-
buffered saline (PBS) and fresh growth medium was added. The
assays were monitored at different times (6 h–24 h) through
optical microscopy.
2.2. Gelatin zymography
2.2.1. Conditioned media preparations
Conditioned media of BCPAP and 8505C confluent cells were
collected after 24 h of culture in absence of serum. The media
were then submitted to extensive dialysis against ultrapure
distilled water at 4 °C and lyophilized. Dried samples were
solubilized in a buffer 50 mM Tris–HCl, pH 7.5.
2.2.2. Zymograpic assay
Aliquots corresponding to 10 μg were used for mono-
dimensional gelatin zymography, that was performed under
non-reducing conditions, on 7.5% SDS-PAGE copolymerized
with 0.1% gelatin, using a minigel lab apparatus (Biorad).
Following the electrophoresis, the SDS was removed from the
gel by washes of 1 h with 2.5% Triton-X 100 in 50 mM Tris–HCl,
pH 7.5. The zymogram was subsequently developed for 18 h at
37 °C ina buffer containing50 mMTris–HCl, pH 7.5, 0.15 MNaCl
and 10 mMCaCl2 [17]. Gelwas stainedwith Coomassie blue and
unstained areas corresponding to zones of digestion were
visualized after destaining with 7%methanol in 5% acetic acid.
2.2.3. Western blotting
Zymographic controls were performed by western blot assay
with purified samples of proMMP-2 and proMMP-9 (kindly
donated by Dr H. Nagase, Imperial College, UK), probed respec-
tively with one of the two monoclonal antibody: anti-MMP-2
mouse mAb (1:1000; Santa Cruz, Heidelberg, Germany) and anti-
MMP-9 mouse mAb (1:1000; Santa Cruz). Following incubation
with the appropriate peroxidase-linked antibody [horseradish
peroxidase-conjugated goat anti-mouse IgG (1:3000; SantaCruz)],
the reaction was revealed by the ECL detection system, using
high performance films (Hyperfilm ECL; Amersham).
2.3. Scanning electron microscopy (SEM)
BCPAP and 8505C cells were seeded in T-25 cell culture flasks
at a concentration of 15×103cell/cm2 and were processed forphenotypic behaviour of papillary and anaplastic thyroid cell
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University of Bologna, Italy. The cell culture flasks were
carefully rinsed with PBS to prevent the cells detachment.
Cells were fixed with Karnowski solution (1.5% glutaraldehyde,
1% paraformaldehyde, 1% cacodylate buffer, pH 7.4) for 10 min.
Flasks with adhering cells were then rinsed three times with
0.1% cacodylate buffer, postfixed for 20 min with 1% OsO4 in
cacodylate buffer, dehydrated with ethanol, and finally dried
with hexamethyldisilazane (Sigma) for 15 min, as described
[18]. Then the specimens were coated with 20 nm-thick
palladium-gold film and examined using a Philips SEM 515
at 15 kV.
2.4. Two dimensional gel electrophoresis
2.4.1. Sample preparations
Cells were grown in the presence of serum until 80–90%
confluence, then they were serum starved for 24 h, harvested
with cell scraper in PBS and lysed in M-RIPA buffer (50 mM
Tris pH 7.5, 0.1% Nonidet P-40, 0.1% deoxycholate, 150 mM
NaCl, 4 mM EDTA) addedwith amixture of protease inhibitors
(0.01% aprotinin, 10 mM sodium pyrophosphate, 2 mM sodi-
um orthovanadate, 1 mM PMSF). The whole cellular lysate
was centrifuged at 14,000 rpm for 8 min to clear cell debris
and stored at −80 °C. Protein concentration in the cellular
extracts was determined using the Bradford method [19].
2.4.2. 2D-IPG
Cell lysates of BCPAPand8505C cellswere submitted to extensive
dialysis against ultrapure distilled water at 4 °C and lyophilized.
Dried samples were solubilized in a buffer containing 4%
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS), 40 mM Tris, 65 mM 1, 4 dithioerythritol (DTE) and a
trace of bromophenol blue in 8 M urea. Aliquots of 45 μg
(analytical gels) or 1.5 mg (preparative gels) of total proteins
were separately mixed with 350 μl of rehydration solution
containing 8 M urea, 2% CHAPS, 10 mM DTE and 0.5% carrier
ampholytes (Resolyte 3.5–10; Amersham), and applied for
isoelectrofocusing (IEF) using commercial sigmoidal IPG strips,
18 cm long with pH range 3.0–10; (Bio-rad, Segrate, Milano,
Italy). The IEF was carried out by linearly increasing the voltage
from200 to 3500 V during the first 3 h, after which focusingwas
continued at 8000 V for 8 h. After the run the IPG strips were
equilibrated with a solution containing 6 M urea, 30% glycerol,
2% SodiumDodecyl Sulphate (SDS), 0.05 M Tris–HCl, pH 6.8 and
2% DTE for 12 min, in order to re-solubilize the proteins and
reduce the disulphuric bonds. The –SHgroupswere then blocked
by substituting the DTE with 2.5% iodoacetamide in the equil-
ibrating buffer. The focused proteins were then separated on
9–16% linear gradient polyacrylamide gels (SDS-PAGE) with
a constant current of 20 mA/gel at 10 °C and the separated
proteins were visualized by ammoniacal silver staining [20].
2.4.3. Image acquisition and data analysis
Silver-stained gels were digitized using a computing densitom-
eter and analyzed with ImageMaster 2D PLATINUM software
(Amersham Biosciences, Sweden). Gel calibration was carried
out using an internal standard and the support of the ExPaSy
molecular biology server, as described elsewhere [21]. Quantita-
tive variations in theprotein expression levelswere calculated asPlease cite this article as: Musso R, et al, Differential proteomic and
lines, J Prot (2013), http://dx.doi.org/10.1016/j.jprot.2013.01.023the volume of the spots (i.e. integration of optical density over
the spot area). In order to correct for differences in gel staining,
the spot volumes relative to the sumof the volumeof all spots on
each gel (%Vol) were calculated by the software.
2.5. Protein identification
2.5.1. N-Terminal microsequencing
It was performed by automated Edman degradation in a
protein sequencer (Procise 419; Applied Biosystems), as previ-
ously described [22].
2.5.2. In-gel digestion and MALDI-TOF analysis
Mass spectrometric sequencingwasperformedwith theVoyager
DE-PRO (Applied Biosystems) mass spectrometer as described
elsewhere [12]. Briefly, proteins were digested using sequencing-
grade trypsin (20 μg/vial). The tryptic peptide extracts were dried
and re-dissolved in 10 μl of 0.1% trifluoroacetic acid (TFA).
The matrix, R-cyano-4-hydroxycinnamic acid (HCCA), was pur-
chased from Sigma-Aldrich. A saturated solution of HCCA (1 μl)
at 2 mg/200 μl in CH3CN/H2O (50:50 v/v) containing 0.1% TFA
wasmixedwith 1 μl of peptide solution on theMALDI plate and
left to dry. MALDI-TOF mass spectra were recorded in the
500–5000 Damass range, using aminimumof 100 shots of laser
per spectrum. Delayed extraction source and reflector equip-
ment allowed sufficient resolution to consider MH±of mono-
isotopic peptide masses. Internal calibration was carried out
using trypsin autolysis fragments at m/z 842.5100, 1045.5642,
and 2211.1046 Da. Peptidemass fingerprintingwas compared to
the theoretical masses from the Swiss-Prot or NCBI sequence
databases using Mascot (http://www.matrixscience.com/).
Typical search parameters were as follows: 50 ppm of mass
tolerance, carbamidomethylation of cysteine residues, one
missed enzymatic cleavage for trypsin, a minimum of four
peptide mass hits was required for a match, methionine
residues could be considered in oxidized form.3. Results
3.1. Cell morphology
Fig. 1 shows the representative optical and scanning electron
micrographs of BCPAP and 8505C cells. BCPAP cells (Fig. 1(A))
grow in monolayer and exhibit a roughly uniform size with an
apparent smooth regular surface, which at SEM (Fig. 1(C))
appears decorated by short microvillous expansions.
At sub-confluence most of the cells produce circular struc-
tures of variable size (Fig. 1(A)), often delimiting small central
cavities, probably corresponding to the “holes” described by
Fabien et al. [23], which mimic the thyroid follicles. In contrast,
the 8505C cells manifest very irregular cellular shapes, sizes and
contours. They showa tendency to overgrow inmultilayer and to
produce long cell surface protrusions of variable size, observable
at both optical (Fig. 1(B)) and scanning microscopy (Fig. 1(D)).
3.2. Cell proliferation
Fig. 2 shows the growth curves of BCPAP and 8505C cells
where each point represents the mean of three replicatesphenotypic behaviour of papillary and anaplastic thyroid cell
Fig. 1 – Representative micrographs of BCPAP and 8505C cells. The figure shows the optical micrographs: A) BCPAP; B) 8505C
(magnification: 20×); and scanning electron micrographs: C) BCPAP; D) 8505C (magnification: 500×).
4 J O U R N A L O F P R O T E O M I C S X X ( 2 0 1 3 ) X X X – X X Xfrom three independent experiments (±SD). Cell proliferation
was evaluated every day from the first 24 h until 9 days after
seeding. As can be observed, the difference in cell prolifera-
tion between the two cell lines is evident at 4 days from
seeding, where the cell density of 8505C cell line is ~30%
higher with respect to B-CPAP cell line. From the 7th day on,
this difference is significantly reduced in conjunction with the
cellular over-confluence decay of both cell lines.Fig. 2 – Proliferation assay of thyroid cancer cells at different
times. Diagram illustrates the growth rate of BCPAP
(continuous line) and 8505C (dotted line) cells, by using the
MTS colorimetric assay.
Please cite this article as: Musso R, et al, Differential proteomic and
lines, J Prot (2013), http://dx.doi.org/10.1016/j.jprot.2013.01.0233.3. Proteomic analysis
Representative 2D proteomic maps of BCPAP and 8505C cells
are shown in Fig. 3. The protein identities are marked with
labels corresponding to the accession numbers of the Swiss-
Prot database and the different isoforms of the same protein
are jointly labelled.
In the present study we have identified 223 protein forms,
corresponding to 147 genes, by MALDI-TOF and/or N terminal
sequencing (for more details see the Supplementary Table
with the catalogue of identified proteins).
For the comparative analysis of protein expression, the
average of three spot values from three different BCPAP and
8505C cells gels was utilized (Fig. 4) and protein levels were
considered significantly different for ≥2-fold variation (Fig. 5).
Out of the 223 identified proteins, 63 protein forms, correspond-
ing to 50 genes, were found to be differentially expressed in
8505C in comparison with BCPAP cells.
The catalogue of differentially expressed proteins is re-
ported in Table 1 with the following information: protein
name, access number of Swiss-Prot database, protein abbre-
viated names, theoretical and experimental pI and MW,
identification methods, matched masses/searched masses
ratio and number of peptide matches that covered the regions
of the protein sequence.
These proteins were clustered into 9 functional catego-
ries, mainly according to the current ontology database
[i.e. 24], with the abrogation of the redundancy. Proteinsphenotypic behaviour of papillary and anaplastic thyroid cell
Fig. 3 – Representative 2D proteomic maps of BCPAP and
8505C cells. 2-DE separation was performed on IPG gel strips
(18 cm, 3.5–10 NL) followed by the SDS-PAGE on a vertical
linear-gradient slab gel (9–16%T). Protein spots of known
identity are labelled with the access number of the
Swiss-Prot/TrEMBL database. When present, different
isoforms of the same protein are jointly labelled.
5J O U R N A L O F P R O T E O M I C S X X ( 2 0 1 3 ) X X X – X X Xwith multifunctional activities were sorted according to
their major function.
Fig. 4 shows the graphs illustrating the relative differences
in density values (expressed as Vol%) of protein spots from
BCPAP (grey colour) and 8505C (black colour) cells. As shown,
the two curves display significant divergences, at various
degrees of amplitude in a number of proteins. Analytically,
the nine protein classes are the following:Please cite this article as: Musso R, et al, Differential proteomic and
lines, J Prot (2013), http://dx.doi.org/10.1016/j.jprot.2013.01.0233.3.1. Metabolic processes
This class represents the most abundant among those identi-
fied inour system. It contains 17protein forms corresponding to
12 isoforms of glycolitic enzymes, 2mitochondrial proteins and
3 proteins of other metabolic processes. It is interesting the
finding that all the identified glycolytic enzymes, including
their isoforms, i.e.: ENOA, G3P, PGK1, KPYM, LDHA and TPIS,
display a higher expression level in 8505C cells with respect to
theBCPAP. These enzymesare key components of the glycolytic
metabolism, but they are also involved in additional functions.
Concurrently, the two proteins of the mitochondrial compart-
ment, ECHMandVATF, appeared at lower intensity levels in the
8505C.
3.3.2. Cytoskeleton and associated proteins
This cluster includes 9 protein forms corresponding to 7
genes. Higher expression levels in 8505C regarded: COF1,
PROF1, VINC, TBB5 and VIME, the latter almost absent in the
BCPAP cells. In contrast, two epithelial markers, i.e. K1C9 and
K2C8, and an actin isoform displayed a lower intensity in
8505C than in BCPAP cells.
3.3.3. Membrane-associated proteins with multiple activities
This group includes 4 protein forms. Three of which, LEG1,
ANXA1 and ANXA2, showed higher expression levels in 8505C
cells while a lower expression level was observed for the
ANXA4.
3.3.4. Calcium binding proteins
Proteins within this cluster include 6 protein forms corre-
sponding to 5 genes. Five of these proteins belong to the S100
family and four of them (two isoforms of S100P, S10A7 and
S10AD) appeared less expressed in the 8505C cells, as did the
calmodulin, a multifunctional calcium transducer; while the
S10A6 appeared more expressed in 8505C cells.
3.3.5. Regulators of cell proliferation
This class includes 5 protein forms. All these proteins (MIF,
NTF2, CCNH and SPB5), except AGR2, are characterized by
higher expression levels in the 8505C cells.
3.3.6. Molecular chaperones/heat shock proteins
This group comprises 9 protein forms corresponding to 5
genes. It is interesting to note that all these proteins,
including their isofoms (CH60, CH10, GRP75, HYOU1 and
PDIA3) displayed lower expression levels in 8505C.
3.3.7. Detoxification processes
This class consists of 6 protein forms, four of which (AK1BA,
3HIDH, PRDX1, and AK1C3) were under-expressed, while two of
them were highly expressed (LGUL and SODM) in 8505C cells.
An altered expression of proteins of the antioxidant protective
system has been also reported by other authors [25] in the
poorly differentiated ARO cells (from anaplastic carcinoma)
with respect to TPC-1 cells (from papillary carcinoma).
3.3.8. Degradation machinery
This cluster includes 3 protein forms: UCHL1 with a high
expression level in 8505C cells, and two subunits of the
proteosome (PSA1 and PSB4) showing lower expression levels.phenotypic behaviour of papillary and anaplastic thyroid cell
Fig. 4 – Global proteomic profiles of BCPAP and 8505C cells. The diagram shows the relative differences in density values
(expressed as Vol%) of protein spots from BCPAP (grey colour) and 8505C (black colour) cells. Each value is the mean of three
independent determinations.
Fig. 5 – Histogram of differentially expressed proteins in BCPAP and 8505C cells, sorted in functional categories. Relative intensity
of protein spots was calculated normalizing the data to the sum of all spot volumes on gels (Vol%). Each value is themean of three
independent determinations. Vertical bars indicate Vol% values. The protein levels were considered significantly different
for≥2-fold change. The data in the graphs are expressed as mean number±SD. For protein symbols, see Table 1.
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Table 1 – Catalogue of the differentially expressed proteins in BCPAP and 8505C cell lines. Table reports the following
information: Protein names, accession numbers (AC) and abbreviated names correspond to the nomenclature used in the
Swiss-Prot database. The experimental values of pI andMW for every isoelectric spot were calculated with ImageMaster 2D
Platinum system; the theoretical values represent the predicted MW and pI for each identified protein according to
Swiss-Prot and TrEMBL database. Identification methods: 1, MALDI-TOF; 2, N-terminal sequencing by automated Edman
degradation; and 3, Western Blotting.
Protein Name AC
Number
Abbreviated
Name
Theor.
MW
Exp.
MW
Theor.
pI
Exp.
pI
ID
methods
%
Masses
Matched
Sequence
coverage (%)
N-terminal residues
3-hydroxyisobutyrate
dehydrogenase, mitochondrial
P31937 3HIDH 35329 31290 8.38 5,62 1 23 21
Actin, cytoplasmic 1 P60709 ACTB a 41737 42000 5.29 5,02 1,3 36 22
ACTB fr b 37228 5,37 1 21 34
Anterior gradient protein 2
homolog
O95994 AGR2 19979 16224 9.03 8,83 1 27 50
Aldo-keto reductase family 1
member B10
O60218 AK1BA 36020 36440 7,66 7,11 1 38 36
Aldo-keto reductase family 1
member C3
P42330 AK1C3 36853 37513 8.06 7,68 1 − 30
Retinal dehydrogenase 1 P00352 AL1A1 54862 50636 6.30 6,81 1 61 49
Annexin A1 P04083 ANXA1 38714 36053 6,57 6,48 1 46 52
Annexin A2 P07355 ANXA2 b 38604 36440 7.57 6,88 1 50 15
Annexin A4 P09525 ANXA4 b 35883 33134 5,83 5,71 1 36 64
Calmodulin P62158 CALM 16838 13928 4.09 4,21 1 57 23
Cyclin-H P51946 CCNH 37643 36945 6.73 6,61 1 48 38
10 kDa heat shock protein,
mitochondrial
P61604 CH10 10932 10902 8.89 8,77 1 40 65
60 kDa heat shock protein,
mitochondrial
P10809 CH60 a 61055 59065 5.70 5,00 1,2 28 26, res. 33-38
CH60 b 59752 5,08 1 78 39
CH60 c 59500 5,17 2 – res 33-38
CH60 sf 54488 5,22 1 38 16
Chloride intracellular channel
protein 1
O00299 CLIC1 26923 31861 5.09 4,92 1 48 43
Cofilin-1 P23528 COF1 a 18502 18547 8.22 6,30 1 45 61
COF1 b 18241 7,08 1 100 52
Coatomer subunit epsilon O14579 COPE 34482 31384 4,98 5,02 1 17 41
Enoyl-CoA hydratase,
mitochondrial
P30084 ECHM 31387 27903 8.34 5,99 1 22 39
Alpha-enolase P06733 ENOA a 47169 46541 7,01 6,22 3 – –
ENOA b 46541 6,37 3 – –
ENOA c 46201 6,62 3 – –
Glyceraldehyde-3-phosphate
dehydrogenase
P04406 G3P a 36053 36274 8.57 7,81 1 73 26
G3P b 36274 8,01 2 – res. 2-11
G3P sf 34355 8,35 1 31 21
Rho GDP-dissociation inhibitor 1 P52565 GDIR1 23207 25087 5,01 4,87 1 23 38
75 kDa glucose-regulated protein P38646 GRP75 73681 74721 5.87 5,34 1 82 24
Hypoxia up-regulated protein 1 Q9Y4L1 HYOU1 fr a 111335 98292 5.16 4,62 1 56 14
HYOU1 fr b 13586 4,62 1 40 12
Keratin, type I cytoskeletal 9 P35527 K1C9 62064 45528 5.14 5,23 1 18 11
Keratin, type II cytoskeletal 8 P05787 K2C8 53704 39754 5.52 4,86 1 32 24
Pyruvate kinase isozymes M1/M2 P14618 KPYM a 57937 59065 7.96 7,42 1 25 39
KPYM b 59500 7,64 1 89 53
Galectin-1 P09382 LEG1 14716 12836 5.30 4,95 1 32 61
Lactoylglutathione lyase Q04760 LGUL 65331 22454 5.12 4,86 1 24 31
Macrophage migration inhibitory
factor
P14174 MIF 12476 11539 7.73 7,71 1 80 21
Nuclear transport factor 2 P61970 NTF2 14478 11457 5.10 4,82 1 37 53
Protein disulfide-isomerase A3 P30101 PDIA3 b 56782 54488 5.98 5,85 1 57 27
Phosphoglycerate kinase 1 P00558 PGK 1 b 44615 41872 8.30 7,79 1 43 28
PGK 1 c 41936 8,06 1 67 13
Peroxiredoxin-1 Q06830 PRDX1 sf 22110 22497 8.27 6,78 1 11 73
Profilin-1 P07737 PROF1 b 15054 13442 8.44 7,57 1 23 56
Proteasome subunit alpha type-1 P25786 PSA1 29556 33335 6.15 6,17 1 100 34
Proteasome subunit beta type 4 P28070 PSB4 29204 23196 5.70 5,50 1 90 34
(continued on next page)
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Table 1 (continued)
Protein Name AC
Number
Abbreviated
Name
Theor.
MW
Exp.
MW
Theor.
pI
Exp.
pI
ID
methods
%
Masses
Matched
Sequence
coverage (%)
N-terminal residues
Cellular retinoic acid-binding
protein 2
P29373 RABP2 15693 13829 5.38 5,41 2 – res. 1-10
Protein S100-P P25815 S100P a 10400 51952 4,75 6,36 1 50 33
S100P b 8625 4,70 1 67 46
Protein S100-A6 P06703 S10A6 a 10180 10786 5.32 4,39 1 100 28
Protein S100-A7 P31151 S10A7 a 11471 9096 6.27 4,99 1 62 39
S10A7 b 12127 5,52 1 35 35
Protein S100-A13 Q99584 S10AD 11471 10484 5.90 5,96 1 33 44
Adenosylhomocysteinase P23526 SAHH 47716 43728 5.92 6,07 1 14 30
Superoxide dismutase [Mn],
mitochondrial
P04179 SODM 24722 23689 8.35 6,95 2 – res. 25-34
Serpin B5 P36952 SPB5 42100 39936 5.72 5,76 1 21 27
Tubulin beta-5 chain P07437 TBB5 a 49671 51008 4.78 4,76 1 52 58
Triosephosphate isomerase P60174 TPIS b 30791 26669 5.65 6,22 1 77 38
Ubiquitin carboxyl-terminal
hydrolase isozyme L1
P09936 UCHL1 24824 26264 5.33 5,34 1 71 67
V-ATPase subunit F Q16864 VATF 13370 10902 5.29 5,10 1 77 68
Vimentin P08670 VIME 53652 44865 5,05 4,53 1 51 43
Vinculin P18206 VINC b 123799 119845 5.50 6,04 1 25 30
8 J O U R N A L O F P R O T E O M I C S X X ( 2 0 1 3 ) X X X – X X X3.3.9. Carrier and scaffold proteins
This group includes 3 protein forms, GDIR1, RABP2 and COPE.
A higher expression level was detected in 8505C cells for
GDIR1, while RABP2 and COPE appeared under-expressed.
A diagram reporting the positive and negative variations of
protein expression in logarithm scale and grouped by class is
illustrated in Fig. 5.
3.4. Cell motility
Fig. 6 shows the sequential steps of the process of “healing” that
both cell lines have undergone. Significant cell migration was
seen at 6 h after the scratch only for the 8505C cells, with
formation of cell protrusions and intercellular contacts at the
woundmargins. After 24 h the scratch was completely covered
by the 8505C cells, differently from the BCPAP cells which
appeared unable to cover the scratch by active migration.
3.5. Gelatinolytic activity
To verify the capability of cells to produce gelatinolytic
enzymes, mainly MMP-2 and MMP-9, as potential invasivity
markers, the conditioned media collected from BCPAP and
8505C cells respectively, were tested by gelatin zymography,
performed after protein separation by mono-dimensional
SDS-PAGE. Fig. 7(A) shows the results of a representative
zymogram of BCPAP and 8505C conditioned media loaded
with the same protein concentration (10 μg/lane). BCPAP
sample (lane 2) contained only two faint gelatinolytic bands
corresponding to monomeric pro-MMP-9 (92 kDa) and
pro-MMP-2 (72 kDa). On the contrary, 8505C sample (lane 3)
showed a higher activity of the pro-enzymatic forms
(pro-MMP-9 and pro-MMP-2), but also displayed a band corre-
sponding toMMP-9 (86 kDa), co-migratingwith immune-stained
standards (Fig. 7(B)).Please cite this article as: Musso R, et al, Differential proteomic and
lines, J Prot (2013), http://dx.doi.org/10.1016/j.jprot.2013.01.0234. Discussion
Thyroid carcinomas are still an open field of studies be-
cause of their numerous histotypes and subtypes with unclear
biological characteristics. In particular, studies of the thyrocyte
and thyroid cancer proteomics, both ex vivo [26–29] and of cell
lines [25] are in aminority comparedwith studies of the genome
and transcriptome [30,31].
In the present researchwe aimed at investigating proteomic
andphenotypic properties thatwould increase the possibility to
better characterizemalignant forms of thyroid tumours. To this
purpose, we performed a comparative analysis of two thyroid
cancer cell lines, derived respectively from papillary (BCPAP)
and anaplastic (8505C) thyroid carcinomas.
Observations at optical and scanning electron microscopes
highlighted a large phenotypical diversity between the two
cell lines. The BCPAP cells display a rather uniform cellular
size, a regular cell shape and plasmamembranes decorated by
short microvillous expansions. Moreover, in most cases, cells
at sub-confluence tend to form circular hollow structures
which resemble the follicular structures of the gland. On
the contrary, the 8505C cells display very irregular cellular
morphology, they grow faster with propensity to overgrow in
multilayer, and produce long cell surface protrusions of
variable size, typical of very aggressive neoplastic cells [18].
Our proteomic analysis highlighted relevant differential
expression of proteins and protein clusters, well matching
with the cell behaviours of the two cell lines respectively.
Firstly, it is interesting to notice that the higher expression
of proteins stimulating cell proliferation (CCNH, GDIR1 and
MIF) [32–34] is detected in the 8505C cells showing higher
growth rates than the BCPAP cells. Conversely a lower
expression of proteins belonging to the folding control
machinery may testify an impaired capability of the 8505Cphenotypic behaviour of papillary and anaplastic thyroid cell
Fig. 6 – Migration of BCPAP and 8505C cells in a scratch wound assay. Panel shows the representative optical micrographs of
B-CPAP and 8505C cells at 0 h, 6 h and 24 h from scratch (magnification: 10×).
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example is the decrement of the PDIA3, a protein that binds
immature forms of thyroglobulin in the exocytosis and endocy-
tosis pathways of thyrocytes, associated with hormonogenesis
[35]. These results are in good agreement with the persistence of
proliferative activities, in the absence of cell differentiation, as
occurs in the anaplastic cancer.
Another significant property of most malignant tumours is
the phenomenon of enhanced anaerobic metabolism, de-
scribed as the “Warburg effect”, which induces acidification of
the cancer environment stimulating the development of a
more aggressive and invasive phenotype. In our system we
observed a higher amount of the glycolytic enzymes in 8505C
cell line compared to the BCPAP, in agreement with the
malignant properties of these cells. It is also relevant to recall
that, in addition to the canonical functions, most glycolytic
enzymes perform other cellular functions. For example, in
some cases ENOA is expressed at the cell surface, where it
may also act as a plasminogen receptor [36], thus mediating
the activation of plasmin and consequent extracellular matrixPlease cite this article as: Musso R, et al, Differential proteomic and
lines, J Prot (2013), http://dx.doi.org/10.1016/j.jprot.2013.01.023degradation and cancer invasion. Similarly, the PGK1, another
over-expressed glycolytic enzyme in the 8505C cells, may
be secreted extracellularly by tumours. In these cases, it
represents a critical target of the “chemokine axis” and an
important regulator of the “angiogenic switch”, essential for
tumour growth and metastasis. In addition, PGK1 is known to
regulate the E-cadherin/β-catenin complex [37], suggesting
that over-expression of this protein in tumours may promote
decreased cell–cell adhesion and potentiate cell migration.
A differential expression of cytoskeleton proteins was also
observed between the two cell lines, probably related with the
observed alterations in the 8505C cell shape and polarity. In
particular, the high expression level of COF1 in 8505C may
have a role in the formation of membrane protrusions and
directional spikes which are known to be associated with a
motile and invasive phenotype [38]. Moreover, the COF1 plays
a crucial role in the apoptotic process, as described in several
researches [39,40]. In addition, the decreased expression of
the epithelial markers K1C9 and K2C8, associated with the
appearance of the mesenchymal marker VIME and with thephenotypic behaviour of papillary and anaplastic thyroid cell
Fig. 7 – Detection of gelatinolytic activity. The figure displays:
A) Representative gelatin zymogram 7.5% SDS-PAGE of
conditionedmedium samples from BCPAP (lane 2) and 8505C
(lane 3) cells and serum sample (lane 1) used as molecular
weight marker; and B) Western Blotting of purified
gelatinases revealed with anti-MMP-2 (lane 1) and
anti-MMP-9 (lane 2) monoclonal antibodies.
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brane trafficking and TGF-β signaling [41], may testify the
occurrence of the epithelial–mesenchymal transition and the
consequent acquisition of a more invasive and aggressive
phenotype. Indeed, other proteins in the 8505C cell proteo-
mics are described as associated with the tumour growth and
metastatic progression: i.e. the S100A6 [42] and LEG1, which,
among several functions, is also considered a co-promoter of
MMP-2 and MMP-9 expression [43] and therefore an enhanc-
er of tumour invasion and metastasis. In support of this
hypothesis is the observation that the 8505C cells produce and
release into the medium a significant quantity of matrix
metalloproteinases MMP-2 and MMP-9.5. Conclusions
The phenotypical features and in vitro behaviours of the BCPAP
and 8505C cell lines, object of the present study, are indicative of
the different malignant potentiality of the tumours from which
the cells were derived. Indeed, the BCPAP cells display traits of
well differentiated non-invasive cells, while the 8505C cells
clearly show the expected characteristics of a very aggressive
phenotype in vivo. The major features are: the exhibition of a
high growth rate, the loss of the epithelial cell polarity, the
transition fromepithelial tomesenchymal cytoskeletalmarkers,
the attitude to cell migration, as demonstrated by the scratch
assay, the extension of long surface protrusion and cell
membrane ruffling, the ability to produce matrix degrading
enzymes (MMPs). Remarkably, the proteomic profiles are in
agreement with phenotypical traits which characterize the twoPlease cite this article as: Musso R, et al, Differential proteomic and
lines, J Prot (2013), http://dx.doi.org/10.1016/j.jprot.2013.01.023studied cell lines. These include: the over-expression of the
glycolytic enzymes by the 8505C cells, which recall the in vivo
Warburg effect typical of malignant tumours; the differential
expression of cytoskeleton proteins, responsible for cell shapes
and cell motility; the differential expression of many proteins
responsible for cell proliferation, and others belonging to other
functional classes. Finally, it is worth mentioning that the
majority of the identified proteins are able to perform a variety
of cellular functions, besides their canonical primary roles, that
when deregulated may become instrumental for cancer growth
and invasion. The differentially expressed proteins may be used
for future applications as biomarkers of thyroid malignancy.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.jprot.2013.01.023.Acknowledgements
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